These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2804022)

  • 1. Medical conditions underlying retinal vein occlusion in patients with glaucoma or ocular hypertension.
    Cole MD; Dodson PM; Hendeles S
    Br J Ophthalmol; 1989 Sep; 73(9):693-8. PubMed ID: 2804022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term safety of dexamethasone implant for treatment of macular edema due to retinal vein occlusion, in eyes with glaucoma or treated ocular hypertension.
    Theodoropoulou S; Ellabban AA; Johnston RL; Cilliers H; Mohamed Q; Sallam AB
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):725-732. PubMed ID: 27878430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of retinal vein occlusion at the Glaucoma Clinic of Hiroshima University.
    Hirota A; Mishima HK; Kiuchi Y
    Ophthalmologica; 1997; 211(5):288-91. PubMed ID: 9286803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal vascular events after intravitreal bevacizumab.
    Mansour AM; Bynoe LA; Welch JC; Pesavento R; Mahendradas P; Ziemssen F; Pai SA
    Acta Ophthalmol; 2010 Nov; 88(7):730-5. PubMed ID: 20039854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Extra-ocular etiologic factors in retinal vein occlusion. Retrospective study of 24 patients].
    Rondeau M; Weber JC; Martinot M; Meyer L; Sahel J; Storck D
    Rev Med Interne; 2000 Mar; 21(3):231-5. PubMed ID: 10763183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension, hyperlipidaemia and thrombophilia as the most common risk factors for retinal vein occlusion in patients under 50 years.
    Schreiberova Z; Rehak J; Babkova B; Sin M; Rybarikova M; Paskova B; Sinova I; Hubnerova P; Maluskova M; Maresova K; Karhanova M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2024 Mar; 168(1):44-49. PubMed ID: 36036564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk factors in central retinal vein occlusion].
    Călugăru D
    Oftalmologia; 2011; 55(2):27-37. PubMed ID: 21888066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular pressure abnormalities associated with central and hemicentral retinal vein occlusion.
    Hayreh SS; Zimmerman MB; Beri M; Podhajsky P
    Ophthalmology; 2004 Jan; 111(1):133-41. PubMed ID: 14711725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical conditions underlying recurrence of retinal vein occlusion.
    Dodson PM; Kubicki AJ; Taylor KG; Kritzinger EE
    Br J Ophthalmol; 1985 Jul; 69(7):493-6. PubMed ID: 4016042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study.
    Sperduto RD; Hiller R; Chew E; Seigel D; Blair N; Burton TC; Farber MD; Gragoudas ES; Haller J; Seddon JM; Yannuzzi LA
    Ophthalmology; 1998 May; 105(5):765-71. PubMed ID: 9593373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for branch retinal vein occlusion. The Eye Disease Case-control Study Group.
    Am J Ophthalmol; 1993 Sep; 116(3):286-96. PubMed ID: 8357052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does type II diabetes predispose to retinal vein occlusion?
    Dodson PM; Clough CG; Downes SM; Kritzinger EE
    Eur J Ophthalmol; 1993; 3(3):109-13. PubMed ID: 8219732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underlying medical conditions in young patients and ethnic differences in retinal vein occlusion.
    Dodson PM; Kritzinger EE
    Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 2)():114-9. PubMed ID: 3857768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemicentral retinal vein occlusion associated with ocular hypertension and clotting abnormality.
    Allen PJ; Brooks AM; Gillies WE
    Ann Ophthalmol; 1993 Mar; 25(3):104-8. PubMed ID: 8460882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with retinal-vein occlusion in Hispanics.
    Appiah AP; Greenidge KC
    Ann Ophthalmol; 1987 Aug; 19(8):307-9, 312. PubMed ID: 3662315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are there medical conditions specifically underlying the development of rubeosis in central retinal vein occlusion?
    Keenan JM; Dodson PM; Kritzinger EE
    Eye (Lond); 1993; 7 ( Pt 3)():407-10. PubMed ID: 7693518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OBSERVED COMPLICATIONS FROM DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA IN RETINAL VEIN OCCLUSION OVER 3 TREATMENT ROUNDS.
    Reid GA; Sahota DS; Sarhan M
    Retina; 2015 Aug; 35(8):1647-55. PubMed ID: 25932545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between retinal vein occlusions and axial length.
    Aritürk N; Oge Y; Erkan D; Süllü Y; Mohajerý F
    Br J Ophthalmol; 1996 Jul; 80(7):633-6. PubMed ID: 8795376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic considerations in bilateral central retinal vein occlusion.
    Tomasini DN; Segu B
    Optometry; 2007 Aug; 78(8):402-8. PubMed ID: 17662929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of risk factors for retinal vein occlusions in patients under 60 years of age].
    Salaun N; Delyfer MN; Rougier MB; Korobelnik JF
    J Fr Ophtalmol; 2007 Nov; 30(9):918-23. PubMed ID: 18046276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.